Daniela Rodrigues-Amorim1, Tania Rivera-Baltanás1, Marta López1, Carlos Spuch2, Jose M Olivares1, Roberto C Agís-Balboa3. 1. Psychiatric Diseases Research Group, Galicia Sur Health Research Institute. Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, CIBERSAM, Spain. 2. Neurology Research Group, Galicia Sur Health Research Institute. Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, CIBERSAM, Spain. 3. Psychiatric Diseases Research Group, Galicia Sur Health Research Institute. Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, CIBERSAM, Spain. Electronic address: roberto.carlos.agis.balboa@sergas.es.
Abstract
OBJECTIVES: Understanding the biological process and progression of schizophrenia is the first step to developing novel approaches and new interventions. Research on new biomarkers is extremely important when the goal is an early diagnosis (prediction) and precise theranostics. The objective of this review is to understand the research on biomarkers and their effects in schizophrenia to synthesize the role of these new advances. METHODS: In this review, we search and review publications in databases in accordance with established limits and specific objectives. We look at particular endpoints such as the category of biomarkers, laboratory techniques and the results/conclusions of the selected publications. RESULTS: The investigation of biomarkers and their potential as a predictor, diagnosis instrument and therapeutic orientation, requires an appropriate methodological strategy. In this review, we found different laboratory techniques to identify biomarkers and their function in schizophrenia. CONCLUSION: The consolidation of this information will provide a large-scale application network of schizophrenia biomarkers.
OBJECTIVES: Understanding the biological process and progression of schizophrenia is the first step to developing novel approaches and new interventions. Research on new biomarkers is extremely important when the goal is an early diagnosis (prediction) and precise theranostics. The objective of this review is to understand the research on biomarkers and their effects in schizophrenia to synthesize the role of these new advances. METHODS: In this review, we search and review publications in databases in accordance with established limits and specific objectives. We look at particular endpoints such as the category of biomarkers, laboratory techniques and the results/conclusions of the selected publications. RESULTS: The investigation of biomarkers and their potential as a predictor, diagnosis instrument and therapeutic orientation, requires an appropriate methodological strategy. In this review, we found different laboratory techniques to identify biomarkers and their function in schizophrenia. CONCLUSION: The consolidation of this information will provide a large-scale application network of schizophrenia biomarkers.
Authors: Yuan Xiao; Wei Liao; Zhiliang Long; Bo Tao; Qiannan Zhao; Chunyan Luo; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Elena I Ivleva; Sarah K Keedy; Bharat B Biswal; Andrea Mechelli; Rebekka Lencer; John A Sweeney; Su Lui; Qiyong Gong Journal: Schizophr Bull Date: 2022-01-21 Impact factor: 7.348
Authors: Eleonora Gatta; Vikram Saudagar; Jenny Drnevich; Marc P Forrest; James Auta; Lindsay V Clark; Henry Sershen; Robert C Smith; Dennis R Grayson; John M Davis; Alessandro Guidotti Journal: Schizophr Bull Open Date: 2021-02-06
Authors: Linda A Antonucci; Nikolaos Koutsouleris; Oemer Faruk Oeztuerk; Alessandro Pigoni; Julian Wenzel; Shalaila S Haas; David Popovic; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Katharine Chisholm; Paris Lalousis; Sian Lowri Griffiths; Theresa Lichtenstein; Marlene Rosen; Joseph Kambeitz; Frauke Schultze-Lutter; Peter Liddle; Rachel Upthegrove; Raimo K R Salokangas; Christos Pantelis; Eva Meisenzahl; Stephen J Wood; Paolo Brambilla; Stefan Borgwardt; Peter Falkai Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-09-17 Impact factor: 5.270
Authors: M A Penedo; T Rivera-Baltanás; D Pérez-Rodríguez; J Allen; A Borrajo; D Alonso-Crespo; C Fernández-Pereira; M Nieto-Araujo; S Ramos-García; C Barreiro-Villar; H J Caruncho; J M Olivares; R C Agís-Balboa Journal: Brain Behav Immun Health Date: 2021-01-07